Taipei, Taiwan

Jaw-Yuan Wen

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Glyconex, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jaw-Yuan Wen. Retrieved from https://idiyas.com/inventor/jaw-yuan-wen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jaw-Yuan Wen in Glycosphingolipid Research

Introduction

Jaw-Yuan Wen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of glycosphingolipid research. His work focuses on human antibodies and their specific binding to extended Type I chain glycosphingolipids.

Latest Patents

Jaw-Yuan Wen holds a patent titled "Anti-extended type I glycosphingolipid antibody, derivatives thereof and use." This patent involves human antibodies and antigen-binding portions that specifically target extended Type I chain glycosphingolipids. He has 1 patent to his name, showcasing his innovative approach in this specialized area.

Career Highlights

Wen is associated with Glyconex, Inc., where he continues to advance research in glycosphingolipids. His work has implications for various therapeutic applications, enhancing the understanding of glycosphingolipid interactions.

Collaborations

He collaborates with notable colleagues, including Tong-Hsuan Chang and Jerry Ting. Their combined expertise contributes to the advancement of research in this field.

Conclusion

Jaw-Yuan Wen's innovative work in glycosphingolipid research highlights his role as a key inventor in the scientific community. His contributions are paving the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…